Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized Studies
Leveraging Digital Tools to Increase COVID-19 Vaccine Adoption
3 other identifiers
interventional
3,637
1 country
1
Brief Summary
COVID-19 misinformation contributed to vaccine hesitancy and preventable illness. This record covers three sequential randomized studies (conducted in Canada and the United States, November-December 2020) testing whether a brief online game helps adults identify COVID-19 and vaccine misinformation. In the game, participants judged whether statements about COVID-19 or COVID-19 vaccines were true or false and immediately received the correct answer with a brief evidence-based explanation, delivered in a game-like format with points, ranks, and feedback. Study 1 (Canada, n = 2,018) randomized participants to complete the knowledge assessment either before playing the game or immediately after playing it. Studies 2 (U.S., n = 822) and 3 (U.S., n = 797) compared the game against the identical corrective content presented as plain text, for general COVID-19 misinformation and vaccine-specific misinformation, respectively. The hypothesis was that gamified corrective information produces more accurate knowledge than non-gamified information. The primary outcome was accuracy in identifying true and false claims; vaccination intention was a secondary outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Nov 2020
Shorter than P25 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2020
CompletedFirst Submitted
Initial submission to the registry
July 31, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedAugust 11, 2026
July 1, 2026
1 month
July 31, 2026
August 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Knowledge Accuracy Score
Mean score across true/false misinformation items, ranging from 0 to 1, with higher scores indicating greater accuracy. Trial 1 included 6 items, Trial 2 included 19 items, and Trial 3 included 17 items. In Trials 1 and 2, "Unsure" responses received 0.5 points; Trial 3 used forced-choice true/false responses.
Single session (Day 1). Assessed immediately post-intervention in all intervention and text-control arms; in Trial 1's assessment-first control arm, assessed at the start of the session before game exposure.
Secondary Outcomes (3)
Vaccination Intention Score - Trial 1
Immediately post-intervention (single session, Day 1); control arm assessed at session start before game exposure.
Vaccination Intention Score - Trial 2
Immediately post-intervention (single session, Day 1).
Vaccination Intention Score - Trial 3
Baseline before randomization and immediately post-intervention during the single study session, Day 1.
Study Arms (6)
Trial 1: Assessment-First Control
OTHERCompleted the knowledge assessment before receiving the gamified refutation quiz (single session).
Trial 1: Game
EXPERIMENTALPlayed the gamified refutation quiz using general COVID-19 items with immediate per-item feedback, followed by the post-intervention assessments.
Trial 2: Text Control
ACTIVE COMPARATORJudged all general COVID-19 items, then received all refutational content as a single static text block without game elements, confirmed reading the text, and then completed the post-intervention assessments.
Trial 2: Game
EXPERIMENTALPlayed the gamified refutation quiz using general COVID-19 items with immediate per-item feedback, followed by the post-intervention assessments.
Trial 3: Text Control
ACTIVE COMPARATORJudged all vaccine-specific items, then received all refutational content as a single static text block without game elements, confirmed reading the text, and then completed the post-intervention assessments.
Trial 3: Game
EXPERIMENTALPlayed the gamified refutation quiz using vaccine-specific items with immediate per-item feedback, followed by the post-intervention assessments.
Interventions
Single-session online game: participants judge true/false statements about COVID-19 (Trials 1-2) or COVID-19 vaccines (Trial 3) and immediately after each response receive the correct answer with a brief evidence-based refutation, within a gamified interface (points, ranks, feedback). 6-19 knowledge items depending on trial.
Identical evidence-based refutational content presented as a single static text block without game elements or item-level feedback. Participants confirmed reading the text before completing the post-intervention assessments.
Eligibility Criteria
You may qualify if:
- Adults aged 18 or older
- Trial 1: Canadian residents residing outside Quebec, with internet access, able to complete the questionnaire in English
- Trials 2-3: Amazon Mechanical Turk workers located in the United States, with a HIT approval rate of at least 95% and more than 100 approved HITs.
You may not qualify if:
- Trial 1: employment in market research, advertising, media, or by a political party
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of South Carolinalead
- Digital Public Squarecollaborator
- U.S. National Science Foundationcollaborator
- Canadian Heritagecollaborator
Study Sites (1)
Online
Columbia, South Carolina, 29208, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 31, 2026
First Posted
August 11, 2026
Study Start
November 20, 2020
Primary Completion
December 28, 2020
Study Completion
December 28, 2020
Last Updated
August 11, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- Beginning upon publication of trial results; no end date.
- Access Criteria
- Data shared with qualified researchers for verification or secondary analysis.
Deidentified per-trial analysis-ready datasets and a data dictionary underlying published results will be available from the authors on reasonable request. Ethnicity is shared in grouped form and geographic region withheld to limit re-identification risk.